127 related articles for article (PubMed ID: 32859133)
21. Stromal expression of actin is a marker of aggressiveness in basal cell carcinoma.
Adegboyega PA; Rodriguez S; McLarty J
Hum Pathol; 2010 Aug; 41(8):1128-37. PubMed ID: 20381122
[TBL] [Abstract][Full Text] [Related]
22. Insight into imiquimod skin permeation and increased delivery using microneedle pre-treatment.
Al-Mayahy MH; Sabri AH; Rutland CS; Holmes A; McKenna J; Marlow M; Scurr DJ
Eur J Pharm Biopharm; 2019 Jun; 139():33-43. PubMed ID: 30771455
[TBL] [Abstract][Full Text] [Related]
23. Multivariate analysis strategies for processing ToF-SIMS images of biomaterials.
Tyler BJ; Rayal G; Castner DG
Biomaterials; 2007 May; 28(15):2412-23. PubMed ID: 17335898
[TBL] [Abstract][Full Text] [Related]
24. Collagen XVII/BP180 protein expression in squamous cell carcinoma of the skin detected with novel monoclonal antibodies in archived tissues using tissue microarrays and digital microscopy.
Stelkovics E; Korom I; Marczinovits I; Molnar J; Rasky K; Raso E; Ficsor L; Molnar B; Kopper L; Krenacs T
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):433-41. PubMed ID: 18633319
[TBL] [Abstract][Full Text] [Related]
25. Spectral characterization of ten cyclic lipids using time-of-flight secondary ion mass spectrometry.
Leefmann T; Heim C; Siljeström S; Blumenberg M; Sjövall P; Thiel V
Rapid Commun Mass Spectrom; 2013 Mar; 27(5):565-81. PubMed ID: 23413216
[TBL] [Abstract][Full Text] [Related]
26. [Specific characteristics of skin basal cell carcinoma invasion].
Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
[TBL] [Abstract][Full Text] [Related]
27. Increased glycosaminoglycans production in sclerosing basal cell carcinoma-derived fibroblasts and stimulation of normal skin fibroblast glycosaminoglycans production by a cytokine-derived from sclerosing basal cell carcinoma.
Moy RL; Potter TS; Uitto J
Dermatol Surg; 2000 Nov; 26(11):1029-36. PubMed ID: 11096389
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy.
Gracia-Cazaña T; Mascaraque M; Lucena SR; Vera-Álvarez J; González S; Juarranz Á; Gilaberte Y
PLoS One; 2019; 14(4):e0215537. PubMed ID: 31017970
[TBL] [Abstract][Full Text] [Related]
29. Investigation of Silver Nanoparticle Induced Lipids Changes on a Single Cell Surface by Time-of-Flight Secondary Ion Mass Spectrometry.
Hua X; Li HW; Long YT
Anal Chem; 2018 Jan; 90(2):1072-1076. PubMed ID: 29260555
[TBL] [Abstract][Full Text] [Related]
30. BerEP4-negative basal cell carcinoma on the palm: case report and review of the literature.
Mleczko A; Franke I; Pokrywka A; Gollnick H; Leverkus M
J Dtsch Dermatol Ges; 2011 Feb; 9(2):140-3. PubMed ID: 20629842
[TBL] [Abstract][Full Text] [Related]
31. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
[TBL] [Abstract][Full Text] [Related]
33. Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
Kadeh H; Saravani S; Heydari F; Shahraki S
Pathol Res Pract; 2016 Oct; 212(10):867-871. PubMed ID: 27567711
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous markers of photo-damage and risk of Basal cell carcinoma of the skin: a meta-analysis.
Khalesi M; Whiteman DC; Doi SA; Clark J; Kimlin MG; Neale RE
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1483-9. PubMed ID: 23833126
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
36. Basal Cell Carcinoma Multiplicity - a Retrospective Analysis of 899 Biopsy-proven Patients from a Single Institute.
Bartos V; Kullová M
Klin Onkol; 2017; 30(3):197-201. PubMed ID: 28612616
[TBL] [Abstract][Full Text] [Related]
37. Lipid analysis of eight human breast cancer cell lines with ToF-SIMS.
Robinson MA; Graham DJ; Morrish F; Hockenbery D; Gamble LJ
Biointerphases; 2015 Jun; 11(2):02A303. PubMed ID: 26319020
[TBL] [Abstract][Full Text] [Related]
38. The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin.
Staibano S; Boscaino A; Salvatore G; Orabona P; Palombini L; De Rosa G
Hum Pathol; 1996 Jul; 27(7):695-700. PubMed ID: 8698314
[TBL] [Abstract][Full Text] [Related]
39. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of biomolecular distributions in rat brain tissues by means of ToF-SIMS using a continuous beam of Ar clusters.
Nakano S; Yokoyama Y; Aoyagi S; Himi N; Fletcher JS; Lockyer NP; Henderson A; Vickerman JC
Biointerphases; 2016 Jun; 11(2):02A307. PubMed ID: 26746166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
